SCHEMBL5964778

SCHEMBL5964778

Cc1cc(C)c(C(=O)n2nc(Nc3ccc(S(N)(=O)=O)cc3)nc2N)c(C)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 10/20 0.71
▸ CDK1 P06493 10/20 0.71
▸ CCNB1 P14635 10/20 0.71
▸ CCNB3 Q8WWL7 10/20 0.71
▸ JAK2 O60674 10/20 0.71
▸ CDK4 P11802 4/20 0.71
▸ CCNA2 P20248 4/20 0.71
▸ CCND1 P24385 4/20 0.71
▸ CDK2 P24941 4/20 0.71
▸ MAPK3 P27361 4/20 0.71
▸ MAPK1 P28482 4/20 0.71
▸ KDR P35968 4/20 0.71
▸ GSK3A P49840 4/20 0.71
▸ GSK3B P49841 4/20 0.71
▸ CCNA1 P78396 4/20 0.71
▸ FGFR2 P21802 3/20 0.71
▸ CSNK1A1 P48729 3/20 0.71
▸ CSNK1D P48730 3/20 0.71
▸ CSNK1E P49674 3/20 0.71
▸ CSNK1G2 P78368 3/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727313 0.90 CDK1 (0.80) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5727292 0.84 CDK1 (0.83) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5726694 0.83 CCNB2 (0.72) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5727180 0.83 CCNB2 (0.70) CCNB2CDK1CCNB1CCNB3JAK2
Jnj-7706621 SCHEMBL1060773 0.83 CDK1 (1.00) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL7089837 0.83 CCNB2 (1.00) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5726856 0.83 CDK1 (0.74) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5726691 0.82 CDK1 (0.78) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL6102470 0.82 CCNB2 (0.70) CCNB2CDK1CCNB1CCNB3JAK2
SCHEMBL5726198 0.82 CDK1 (0.74) CCNB2CDK1CCNB1CCNB3JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1712550-A2 Substituted triazole diamine derivatives as kinase inhibitors Ortho-McNeil Pharmaceutical, Inc. (US) 2006-10-18 — — EP disclosed
Send feedback